[1]郭津生, 沈沪佳.非酒精性脂肪性肝炎发病机制的研究进展[J].国外医学.消化系疾病分册, 2005, 25 (5) ∶269-272.
|
[2]Bacon BR, Powell LM, Adams PC, et al.Molecular medicine and hemochromatosis:at the cross roads[J].Gastroenterology, 1999, 116 (1) ∶193-207.
|
[3]弭希峰, 黄子成, 王木成, 等.非酒精性脂肪肝患者血清铁、转铁蛋白、血清铁蛋白水平测定[J].上海医药, 2006, 27 (11) ∶517-518.
|
[4]刘少锋, 韩真, 何池义.茶多酚对高脂饮食诱发大鼠非酒精性脂肪肝的防护作用以及对CYP2E1表达的影响[J].中西医结合肝病杂志, 2005, 15 (4) ∶227-230.
|
[5]杨晴英, 方立环, 赵俊霄, 等.不同固定剂与铁染色结果的影响[J].诊断病理学杂志, 2000, 9 (5) ∶313-314.
|
[6]Marchesini G, Brizi M, Bianchi G, et al.Nonalcoholic fatter liver dis-ease:a feature of the metabolic syndrome[J].Diabetes, 2001, 50 (8) ∶1844-1850.
|
[7]Aigner E, Theurl I, Theurl M, et al.Pathways underlying iron accu-mulation in human nonalcoholic fatty liver disease[J].AmJ Clin Nu-tr, 2008, 87 (5) ∶1374-1383.
|
[8]Zhuang J, Wang Z, Liu J, et al.Putative mechanism of experimental immunological liver injury and influence of iron low-load on the in-jury in rat[J].Wei Sheng Yan Jiu, 2004, 33 (6) ∶687-689.
|
[9]Valenti Luca.Iron Depletion by Phlebotomy Improves Insulin Resist-ance in Patients With Nonalcoholic Fatty Liver Disease and Hyperfer-ritinemia∶Evidence from a Case-Control Study[J].American Journal of Gastroenterology, 2007, 102 (6) ∶1251-1258.
|
[10]Facchini FS, Hua NW, Stoohs RA.Effect of iron depletion in carbo-hydrate-intolerant patients with clinical evidence of nonalcoholical fatty liver disease[J].Gastroenterology, 2002, 12 (2) ∶931-939.
|
[11]刘芳, 路长, 赵英仁.铁过负荷与非酒精性脂肪性肝病[J].国外医学.生理、病理科学与临床分册, 2003, 23 (5) ∶545-547.
|
[12]谭力学, 李孝生.铁与慢性肝损伤[J].国外医学.医学地理分册, 2003, 24 (5) ∶148-151.
|
[13]夏婷, 方建培.去铁胺和deferiprone的临床研究进展[J].国外医学.儿科学分册, 2005, 32 (5) ∶40-42.
|
[1] | Decai KONG, Xiaojing ZHANG, Yangguang YUN, Haoyu DUAN, Junfeng YE. Risk factors for biliary stricture and prognosis after orthotopic liver transplantation[J]. Journal of Clinical Hepatology, 2024, 40(11): 2253-2259. doi: 10.12449/JCH241119 |
[2] | Wanshu LIU, Lijun SHEN, Qinghui ZHAI, Shaojie XIN, Shaoli YOU. Risk factors for acute variceal bleeding in acute-on-chronic liver failure and its influence on prognosis[J]. Journal of Clinical Hepatology, 2022, 38(11): 2532-2536. doi: 10.3969/j.issn.1001-5256.2022.11.018 |
[3] | Siqin LIU, Xiaomei WANG, Xia LI, Luwen LIANG, Ke WANG, Rui WANG. Covert hepatic encephalopathy in liver cirrhosis: Risk factors and prognosis[J]. Journal of Clinical Hepatology, 2022, 38(2): 359-364. doi: 10.3969/j.issn.1001-5256.2022.02.020 |
[4] | Chengsi ZHAO, Weijie YAO, Peng YUAN, Zuozheng WANG. Time distribution of risk factors for secondary pancreatic infection in acute pancreatitis[J]. Journal of Clinical Hepatology, 2022, 38(7): 1686-1690. doi: 10.3969/j.issn.1001-5256.2022.07.044 |
[5] | Lu LI, Huaibin ZOU, Manman XU, Yu CHEN. Risk factors for gestational diabetes mellitus in pregnant women with chronic HBV infection and its influence on maternal and fetal outcomes[J]. Journal of Clinical Hepatology, 2021, 37(10): 2303-2307. doi: 10.3969/j.issn.1001-5256.2021.10.009 |
[6] | Yuling DUAN, Zanjie FENG, Guoxin FAN, Lei WANG, Kangwei LIU, Cijun PENG. Risk factors for open pancreatic necrosectomy in patients with severe acute pancreatitis: An analysis based on the surgical step-up approach[J]. Journal of Clinical Hepatology, 2021, 37(4): 893-897. doi: 10.3969/j.issn.1001-5256.2021.04.033 |
[7] | Chen XU, Wei YANG, Jie GU, Weizhong ZHOU, Haibin SHI. Incidence rates of hyperamylasemia and acute pancreatitis after percutaneous transhepatic biliary stenting and related risk factors[J]. Journal of Clinical Hepatology, 2021, 37(4): 882-887. doi: 10.3969/j.issn.1001-5256.2021.04.031 |
[8] | Zhang DaLi, Feng DanNi, Zhang LiJuan, Tang RuJia, He Xi, Zhou Xia, Gao YinJie, Liu ZhenWen, Liu HongLing. Risk factors for recurrence after liver transplantation in patients with hepatocellular carcinoma and their prognosis[J]. Journal of Clinical Hepatology, 2020, 36(9): 1985-1989. doi: 10.3969/j.issn.1001-5256.2020.09.015 |
[9] | Zhong Rui, Yan YongFeng, Jiang Xin, Xu Huan, Peng Yan, Wang Min, Fu WenGuang, Tang XiaoWei. Clinical features of acute pancreatitis with metabolic syndrome and influencing factors for prognosis[J]. Journal of Clinical Hepatology, 2020, 36(8): 1794-1798. doi: 10.3969/j.issn.1001-5256.2020.08.023 |
[10] | Yan YongFeng, Jiang Xin, Zhong Rui, Xu Huan, Peng Yan, Tang XiaoWei. Clinical features and prognosis of acute pancreatitis with nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2020, 36(5): 1091-1096. doi: 10.3969/j.issn.1001-5256.2020.05.028 |
[11] | Yu Qiang, Wang Jing, Liu JinFeng, Yan TaoTao, Feng YaLi, He YingLi, Dai XiaoMin, Chen TianYan, Zhao YingRen, Zhu YaGe. Current status of hepatitis B virus infection among pregnant women in Shaanxi Province, China and risk factors for mother-to-infant transmission[J]. Journal of Clinical Hepatology, 2019, 35(7): 1489-1492. doi: 10.3969/j.issn.1001-5256.2019.07.013 |
[12] | Wang XianPeng, Meng XianZhi. Risk factors for gallstones complicated by acute biliary pancreatitis[J]. Journal of Clinical Hepatology, 2018, 34(8): 1728-1732. doi: 10.3969/j.issn.1001-5256.2018.08.027 |
[13] | Li Ying, Zhan Jing, Wang ZhongFeng. Prognostic factors for patients with hepatitis B virus-related acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2017, 33(3): 497-501. doi: 10.3969/j.issn.1001-5256.2017.03.020 |
[14] | Wang FengJiao, Liu MingJiang, Wu RuiHong, Niu JunQi. A multivariate logistic regression analysis of short-term prognosis of patients with hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2017, 33(4): 711-714. doi: 10.3969/j.issn.1001-5256.2017.04.022 |
[15] | Hu WeiLin. Risk factors for hypertriglyceridemia-induced acute pancreatitis[J]. Journal of Clinical Hepatology, 2017, 33(8): 1518-1521. doi: 10.3969/j.issn.1001-5256.2017.08.022 |
[16] | Shi XinXing, Zhang YanQiong, Zhu Peng, Yan GuoHua, Zhang ZhangJiang, Wang YuMing. Prognostic risk factors in patients with hepatitis B virus- related acute- on- chronic liver failure[J]. Journal of Clinical Hepatology, 2016, 32(4): 700-705. doi: 10.3969/j.issn.1001-5256.2016.04.018 |
[17] | Wu XiaoQing, Wan Hong. Causes of liver failure and impact analysis of prognostic risk factors[J]. Journal of Clinical Hepatology, 2013, 29(4): 294-296+304. |
[18] | Liu HongHong, Fu JunLiang, Fu BaoYun, Zhang Zheng, Xu RuoNan, Luo ShengQiang, Shi Ming, Li YongGang, Wang FuSheng. The pathogenesis and risk factors related to prognosis of primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2012, 28(2): 153-155. |
[19] | Lu: RiYing, Li ShiXiong, Wu JiZhou, Zhu YuJia, Fu ShaoPing. Development of a prognostic factors model for severe hepatitis[J]. Journal of Clinical Hepatology, 2012, 28(10): 789-792. |
[20] | Ding HuiGuo, Gao GuiJu, Chen Tao, Jin Rui. Prognosis of Severe Types of Virous Hepatitis: Study on Mutiple Risk Factors.[J]. Journal of Clinical Hepatology, 2002, 18(5): 297-299. |
1. | 李志敏,李诗然,谢婧娴,张娇,李鹏飞,曾思羽,杨勇. 妊娠合并高甘油三酯血症诊治和管理研究进展. 中国临床药理学与治疗学. 2024(12): 1380-1388 . ![]() |